Related references
Note: Only part of the references are listed.Lamivudine Maintenance Beyond One Year After HBeAg Seroconversion Is a Major Factor for Sustained Virologic Response in HBeAg-Positive Chronic Hepatitis B
Hyun Woong Lee et al.
HEPATOLOGY (2010)
Factors That Predict Response of Patients With Hepatitis B e Antigen-Positive Chronic Hepatitis B to Peginterferon-Alfa
Erik H. C. J. Buster et al.
GASTROENTEROLOGY (2009)
Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B
Stefan Zeuzem et al.
JOURNAL OF HEPATOLOGY (2009)
A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update
Emmet B. Keeffe et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2008)
Treatment predictors of a sustained virologic response in hepatitis B and C
Annika Kau et al.
JOURNAL OF HEPATOLOGY (2008)
Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B
Emmet B. Keeffe et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Revisiting the natural history of chronic hepatitis B: Impact of new concepts on clinical management
Man-Fung Yuen
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Lamivudine resistance in patients with chronic hepatitis B: Role of clinical and virological factors
Alexander J. V. Thompson et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
TT Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Therapeutic implications of hepatitis B virus genotypes
CJ Liu et al.
LIVER INTERNATIONAL (2005)
Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea
SH Bae et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2005)
Hepatitis B virus genotypes in korea: An endemic area of hepatitis B virus infection
BC Song et al.
INTERVIROLOGY (2005)
Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma
HLY Chan et al.
GUT (2004)
Four years of lamivudine treatment in Chinese patients with chronic hepatitis B
TT Chang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Determinants for sustained HBeAg response to lamivudine therapy
RN Chien et al.
HEPATOLOGY (2003)
Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: Analysis and review of the literature
H Mommeja-Marin et al.
HEPATOLOGY (2003)
A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy
MF Yuen et al.
GUT (2003)
Long-term safety of lamivudine treatment in patients with chronic hepatitis B
ASF Lok et al.
GASTROENTEROLOGY (2003)
Hepatitis B genotypes in chronic hepatitis B and lamivudine therapy
MF Yuen et al.
INTERVIROLOGY (2003)
Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B
RP Perrillo et al.
HEPATOLOGY (2002)
Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial
SW Schalm et al.
GUT (2000)
Share Paper
